Progression of Untreated Pulmonary Ground Glass Opacity

Shanghai Zhongshan Hospital2,000 enrolled

Overview

In this study, about 2000 GGO patients will be included for a 5-year follow-up. The aim of this study is to elucidate the biological nature of pulmonary GGO lesion and provide evidence for GGO treatment.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Lung Cancer

Interventions

No intercentionOTHER

No intercention

Eligibility

Sex: ALLMin age: 35 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 35-80 years' old * found pulmonary GGO with chest CT scan and CT follow-up after 3 months shows that the GGO remains * Diameter of GGO \> 5mm and \< 3cm * Solid component of GGO in pulmonary window \< 5mm * signed informed consent form Exclusion Criteria: * receiving immunosuppressor or steriods * receiving chemo- or radio- therapy * can not receive regular follow-up

Locations (1)

Zhongshan Hospital

Shanghai, Shanghai Municipality, China

RECRUITING

Outcomes

Primary Outcomes

Changes from baseline GGO diameter

Time frame: 6 months, 1year, 2 years, 3 years, 4 years and 5 years

Changes from baseline GGO CT index.

Time frame: 6 months, 1year, 2 years, 3 years, 4 years and 5 years

Central Contacts

Qun Wang

CONTACT

+86-64041990-2018 wang.qun@zs-hospital.sh.cn

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.